Astromicin
|  | |
| Systematic (IUPAC) name | |
|---|---|
| 2-amino-N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-[(2R,3R,6S)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2,5-dihydroxy-6-methoxycyclohexyl]-N-methylacetamide | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names | 
| Routes of administration | IV | 
| Legal status | 
 | 
| Identifiers | |
| CAS Number | 55779-06-1  | 
| ATC code | none | 
| PubChem | CID 65345 | 
| ChemSpider | 4447577  | 
| UNII | 7JHD84H15J  | 
| KEGG | D07470  | 
| ChEBI | CHEBI:37923  | 
| ChEMBL | CHEMBL1909053  | 
| Chemical data | |
| Formula | C17H35N5O6 | 
| Molar mass | 405.48 g/mol | 
| 
 | |
| 
 | |
|   (what is this?)  (verify) | |
Astromicin (INN)(also frequently referenced in scientific journal articles as compounds Fortimicin A/B ) is an aminoglycoside antibiotic. Synthesized from Micromonospora olivasterospora(also named with additional o in olivoasterospora).
| 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.